--- title: 'CEO | Persuasive at NLC Health Ventures' canonical: 'https://feeny.ai/job/ceo-persuasive-nlc-health-ventures-utrecht-83r3ffmkg6p6' type: 'job' last_seen: '2026-09-12' --- # CEO | Persuasive at NLC Health Ventures - **Company:** NLC Health Ventures - **Location:** Utrecht, Canada - **Posted:** 2026-07-03 - **Last confirmed live:** 2026-09-12 - **Apply:** https://job-boards.greenhouse.io/nlcventures/jobs/7793952003 ## Job description Chief Executive Officer Company stage: Pre-Commercial start-up (Diagnostics/IVD) Location: Hybrid with regular travel to Utrecht Travel: The role requires travel for investor roadshows, pitch events, and partner meetings across Europe, with US-facing engagement as the go-to-market develops. Compensation: This role starts as a fractional engagement (about 2 days per week) for a founder-minded leader who understands the risk and reward profile of early-stage company building. Compensation is weighted toward equity and performance-linked milestones, with a modest cash component available in line with the current funding position. Cash scales materially upon close of the next financing round. Equity mechanism and structure to be confirmed. ## About the Company Persuasive BV is a Netherlands-based medical diagnostics company spun out of NLC and built on technology licensed from Utrecht University Hospital. We develop technology that isolates and measures diagnostic particles directly from blood, addressing a gap in current chest pain diagnostics where speed and accuracy of testing remain a critical clinical bottleneck. After seven years of development, the technology is entering its final stage, with large-scale verification and validation planned over the next one to two years alongside preparation for launch as a testing service in the Netherlands. The business case is strong with limited direct competition in the space. Purpose of the Role We are seeking a hands-on CEO to lead the company through its next phase of final development and first commercialization. This role was created as the founding CEO transitions to a dedicated CTO position, taking full ownership of technology, IP, and regulatory matters. The incoming CEO focuses exclusively on commercial strategy, investor relations, and go-to-market execution. The business case is strong with limited / no competition. The technology is entering the final development stage. Large-scale verification and validation will be done in the next 1-2 years while preparing for launching as a testing service in NL in parallel. The CEO’s role is to convert this foundation into a commercially sustainable business model, refine it for future scaling, and lead the company toward international expansion and long-term strategic relevance. This is a CEO role requiring commercial strategy development and fundraising. Over the next 12 to 24 months, the CEO will: - Select a business model from the available options and build a credible go-to-market plan for Europe, with potential US expansion - Align shareholders and position the company for strategic partnerships and growth - Sharpen commercial focus, pricing, positioning, and marketing - Work alongside the CTO - Strengthen and professionalise PERSUASIVE’s proposition for pitching to investors - Fully dedicated to fundraising activities Key Responsibilities: - Evaluate available business model options, select the most commercially viable path, and develop a 12 to 24-month execution plan covering go-to-market, pricing, and positioning for the European market with a view to US expansion. - Secure €1 to 2M in the next funding round through active outreach to angels, corporate VCs, and strategic partners, building a credible financial narrative around the verification and validation timeline and commercialization milestones. - Represent PERSUASIVE externally with clinicians, strategic partners, and investors, while preparing the company for first commercialization in Europe, including US expansion. - Drive fundraising efforts by actively engaging with suitable investors and leveraging technical and commercial acumen - Identify and remove barriers to adoption by spending time with customers to understand clinical applications, key stakeholders, hospital budgeting, workflows, training, and usage challenges, and translating these insights into action. - Lead and refocus a small team on execution by setting clear priorities, ownership, and accountability, and eliminating non-essential activity. ## Requirements - Demonstrated success raising from angels, corporate VCs, and grant or foundation sources in medtech or IVD, with an existing warm investor network in the Netherlands, Belgium, or Germany; a strong differentiator. - Senior leadership experience in In-Vitro-Diagnostics / biomarker detection technology / clinical laboratory, ideally in a start-up/scale-up environment - Experience shaping go-to-market strategies, pricing, and commercial models for innovative medical products - Experience and network in the Cardiology / Cardiovascular space preferred - Comfortable operating in a small, fast-moving organization where the CEO leads from the front - Experience working across European markets; exposure to the US market is a strong plus - Strong commercial judgment, resilience, and decisiveness, combined with a genuine motivation to improve outcomes for chest pain patients ## About NLC NLC Health Ventures is a leading healthtech and biotech innovation platform based in Amsterdam, combining venture building and fund management across Europe and North America. With 40-45 employees, NLC manages four captive funds investing in ventures from pre-seed to Series B-C, and is fundraising for a fifth fund. The funds have a diverse LP base and are invested in over 70 companies. NLC values a collaborative, open, and impact-driven culture, where team members’ ideas and contributions truly matter. ## About NLC Health Ventures ## Company Overview - **One-liner**: NLC Health Ventures is a world-leading healthtech venture builder and early-stage investor that finds, builds, and scales transformative health technologies to bring scientific discoveries to patients. - **Entity Type**: Private (Venture Builder & Investor) - **Headquarters**: Amsterdam, Netherlands - **Founded**: 2014 - **Founders**: Not publicly available ## Core Business - **Primary industry/industries**: Healthtech Venture Building & Early-Stage Investment; Therapeutics; Medtech (Orthopedics & Spine, Cardiovascular & IGT); New Markets (neonatal, respiratory, enterprise hospital software) - **Target customers**: B2B; scientific founders, academic institutions, healthcare systems, and patients - **Mission or purpose statement**: "To transform patients' lives by bringing groundbreaking scientific discoveries to life" and "to bring science to life by bridging the gap between scientific discoveries and market-ready solutions that transform patients’ lives." ## Products & Services - **Venture Building**: NLC identifies scientific inventions and builds them into standalone healthtech ventures, providing operational, strategic, and funding support from concept to market. - **Early-Stage Investment**: NLC manages captive funds and has raised over €190M+ for its portfolio ventures, investing across therapeutics, medtech, and new market technologies. - **Portfolio Ventures**: NLC has built 110+ ventures, including XtRNA Bio (tRNA biotherapeutics for rare genetic diseases) and ROB'E (robotic endoscopy), among others. ## Market Standing - **Valuation/Market Cap**: Not disclosed (private venture builder) - **Key Metric**: Over €190M+ raised by NLC ventures; 110+ ventures built; 2M+ patients impacted; 1500+ technologies assessed annually - **Notable Investors/Partners**: Not publicly listed, but NLC is a certified B Corporation and part of its community of leaders. The company has 4 captive funds. - **Growth Signals**: 40+ healthcare experts on staff, supported by over 1,000 experts globally; 110+ ventures built; 2M+ patients impacted; active hiring for senior leadership roles (CEO, CTO, Scientific Director) across portfolio companies. ## Competitive Advantages - **Proprietary Venture-Building Model**: NLC’s unique approach uses data and learnings to systematically find inventions and create ventures at scale, bridging the gap between academic science and market-ready solutions. - **Deep Healthcare Expertise**: A team of 40+ healthcare, finance, and business professionals, supported by 1,500+ global experts, provides unparalleled domain knowledge in therapeutics, medtech, and new markets. - **Certified B Corporation**: Commitment to using business as a force for good, driving a global movement of leaders focused on impact. - **Proven Track Record**: 110+ ventures built, €190M+ raised, and 2M+ patients impacted, demonstrating a repeatable model for success. ## Strategic Focus - **Current priorities**: Expanding its portfolio across therapeutics (gene therapy, tRNA biotherapeutics), medtech (robotic endoscopy, orthopedics, cardiovascular), and new markets (neonatal, respiratory, enterprise hospital software). Actively hiring for senior leadership roles (CEO, CTO, Scientific Director) to scale portfolio companies toward first-in-human studies and market entry. - **Direction for growth**: Deepening its platform-based approach (e.g., tRNA therapeutics for rare diseases) and expanding into new therapeutic modalities and delivery systems (AAV, LNP). Scaling ventures from preclinical to IND-enabling studies and clinical readiness. ## Why Work Here - **Culture**: NLC emphasizes a culture of openness, transparency, and impact over titles. Core values include being open, optimistic, together, and decisive. The company is a certified B Corporation, committed to using business as a force for good. - **Hybrid Working Model**: NLC offers a flexible hybrid working model, balancing office time and remote work. Many roles are remote-first (preferred Europe), with some requiring travel to partner sites. - **Compensation & Benefits**: Staff Participation Plan (SPP) and Long Term Incentive Plan (LTIP) allow employees to share in the company's success. Yearly learning and development budget. Unlimited/unrecorded holidays. Primarily equity-based compensation for early-stage venture roles, with a modest base salary until fundraising. - **Culture**: Values include openness, optimism, collaboration ("Together"), and decisiveness. The company prioritizes impact over titles and fosters a transparent, innovative environment. Certified B Corporation. - **Team**: 40+ healthcare, finance, and business professionals, supported by over 1,000 experts worldwide. 144 total employees (as per Built In). - **Diversity & Inclusion**: Committed to being an equal opportunity employer; believes diversity drives innovation. ## Sources 1. [nlc.health](https://www.nlc.health/) 2. [nlc.health/careers](https://www.nlc.health/careers) 3. [job-boards.greenhouse.io](https://job-boards.greenhouse.io/nlcventures/jobs/7731781003) 4. [job-boards.greenhouse.io](https://job-boards.greenhouse.io/nlcventures/jobs/7731839003) 5. [builtin.com](https://builtin.com/company/nlc-health-ventures) ## Other roles at NLC Health Ventures - [CEO | Occlunova](https://feeny.ai/job/ceo-occlunova-nlc-health-ventures-minnesota-f8ps8n4g8c56) — Minnesota, United States - [Investment Director](https://feeny.ai/job/investment-director-nlc-health-ventures-amsterdam-5686s8e1kkay) — Amsterdam, Netherlands - [Capital Acquisition Manager](https://feeny.ai/job/capital-acquisition-manager-nlc-health-ventures-amsterdam-1nar4hpxd8pt) — Amsterdam, Netherlands - [Head of Product and Strategy | ROB'E](https://feeny.ai/job/head-of-product-and-strategy-rob-e-nlc-health-ventures-hamburg-yz48avadr4g8) — Hamburg, Germany - [CEO (Gene Therapy) XtRNA](https://feeny.ai/job/ceo-gene-therapy-xtrna-nlc-health-ventures-nijmegen-the-p4ky3g3qvnks) — Nijmegen the, Netherlands